《中国药物应用与监测》杂志 第16卷 第1 ～ 6期文题索引

专家论坛

真实世界大样本用药人群信息化安全性评价实践及流程规范·······················································郭代红，贾王平，王啸宇，寇 炜，马 亮，陈 超，赵粟裕（3）：127

药物评价研究及进展····························································谢婷婷，郭代红（4）：191

临床评价

替诺福韦酯阻断乙型肝炎病毒母婴传播的疗效和安全性的Meta分析···················黄 丽，龙云铸，罗圣平，谭秋红，刘 珂（1）：1

急性冠脉综合征患者PCI术后CYP2C19和PON1 Q192R基因多态性与氯吡格雷抗血小板临床疗效和出血风险的相关性研究··································徐晓宇，彭文星，井浣雨，林 阳（1）：7

神经介入术后CYP2C19基因多态性与氯吡格雷治疗药物调整·················陈 玥，刘 磊，高 雪，朱 曼，柴 栋（2）：63

紫杉醇（白蛋白结合型）联合替吉奥对晚期胆管癌一线化疗患者的临床观察研究·········································································张 娟，李 涛，秦博宇，孟宪阳，张素洁，胡 毅（2）：67

坎地沙坦预防治疗偏头痛的疗效及安全性的Meta分析···············王金明，洪伟勇，申慧玲，方 芳，陈 敏（3）：132

CYP3A5基因多态性对肾病患者他克莫司临床应用指导分析····························································李晓琳，刘 冰（3）：137

肾移植术后患者服用咪唑立宾致血尿酸升高的相关研究·············································侯文婧，温爱萍，林 俊（4）：196

复明片联合利拉鲁肽在治疗糖尿病视网膜病变中的应用及对患者IGF-1、VEGF水平影响······························高利娟，李月红，李 珊，吴玲玲（4）：199

伏立康唑谷浓度在血液科患者中的分布特征及影响因素········································································张瑞霞，张 艳，张 弋，付 鹏，冯 浩（4）：204

喹硫平缓释片治疗成人精神分裂症有效性和安全性的Meta分析········································································李 超，杨子贤，张 田，李 婷，薛 薇，谭 玲（5）：259

英夫利西单抗治疗中重度银屑病的疗效及安全性研究·············齐 婧，解 方，刘卉莹，宋翠豪，李承新（6）：325

重组人血管内皮抑制素联合CO2点阵激光治疗瘢痕疙瘩的临床疗效观察······························田 超，王露萍，许尔长，张兰芳（6）：328

实验研究

Child-Pugh C级患者伏立康唑血药浓度监测结果分析································赵庆国，任秋霞，杜春辉，王艳红（1）：11

HPLC法测定利咽含片中绿原酸含量···············································王欢欢，黄晓舞，白 林（1）：14

枸橼酸钾泡腾片的研制和质量评价···············································孙华燕，黄晓舞，白 林（2）：71

基于冶疗药物监测的拉莫三嗪个体化用药分析·················周甜甜，王夏红，张慧芝，张 颖，王 录（2）：75

去氢骆驼蓬碱磁固体脂质纳米粒的处方和制备工艺的优化·······························木尼热·库尔班，唐小慧，王 梅（3）：141

去甲万古霉素血药浓度检测方法的建立及评价···············董 迪，毛 璐，宋 菲，张 威，甄健存（3）：146

刺山柑体外抗肿瘤活性提取物的筛选研究············买地哪木·色迪克，周彦霞，周晓涛，王 梅（4）：208

苦参素胶囊对小鼠急性酒精性肝损伤的影响·························································方 慧，鲁长俊，吕 悦，郑珊娇，俞婷婷，王 寅，郑 英（4）：212

黄硝创伤方抑菌有效药味优选研究······························张玉萌，何新荣，栗晓东，魏 静（4）：216

反相高效液相色谱法测定老年癫痫患者血清中丙戊酸的浓度···············黄芳华，陈红君，唐原君，朱李飞，余自成（5）：264

两波长变化HPLC法同时测定护肝片中5 种主要成分的含量···························································唐 霄 ，张翠欣（5）：267

硝酸异山梨酯对STEMI患者心肌缺血再灌注损伤的后处理效应······························杜正强，刘 盼，梅少平，宋达琳（6）：331

重症患者碳青霉烯类药物血药浓度监测分析······························徐银丽，郭晓芳，江翊国，梁 培（6）：335

利奈唑胺致血小板减少与二氧化碳分压相关性分析······························王天琳，张 欢，李 晶，夏 蕾（6）：339

配伍对川芎特征图谱的影响及指标成分含量变化研究····························································李 外，何新荣（6）：343

临床药师园地

对1例肾功能延迟恢复的老年患者合理使用万古霉素的药学监护···············································张青霞，王 哲，闫素英（1）：17

临床药师对肺部感染伴房颤患者的用药安全性监护························································· 刘慧敏，郑 芳，李 鹏，陈富超，李 聪，李志浩，李春雷（1）：21

1例行血浆置换的重症肾衰竭患者联合使用抗感染药物的药学监护·················蔡 乐，雷雪梅，汤智慧，王东晓，朱 曼（2）：78

从1例INR未达标颅内出血死亡的肺栓塞患者探讨老年患者华法林的合理使用···············································张青霞，赵思邈，闫素英（2）：82

1例对多种胰岛素制剂过敏的妊娠期糖尿病患者的用药分析及药学监护···············································刘银萍，董玲芳，王 艳（2）：86

1例基于万古霉素治疗药物监测的新生儿败血症药学监护·············································王司允，李 馨，付秀娟（3）：150

1例舌咽神经痛合并高血压的老年患者药学监护···············梁锦湄，刘智慧，朱 曼，刘灵灵，赵国利（3）：154

1例带状疱疹后神经痛患者止痛治疗的药学监护······························孙秋艳，邓礼娟，杜 彪，陈 晨（3）：158

1例重症肺炎合并感染性心内膜炎患者的药学监护··························································向道春，程刚英，赖永继，周 庆，刘 珏，王 奕，邓艾平（4）：219

1例重度烧伤肠外营养支持治疗患者血糖控制的药学监护····························································唐微艳，任海霞（4）：223

临床药师参与1 例脑梗死后出血转化患者的药学监护···············向道春，周 庆，刘 珏，王 奕，邓艾平（5）：271

一例二尖瓣机械瓣膜血栓患者的药学监护·············································彭文星，林 阳，张进华（5）：275

1例腹膜透析相关感染合并继发性甲状旁腺功能亢进患者的药学监护···············代瑞甫，蔡 乐，朱 曼，张艳秀，陈 勤（6）：347

1例华法林联合卡培他滨致结肠癌患者消化道出血病例分析·············································袁晓刚，高 攀，杨彦伟（6）：351

不良反应监测

334例儿童药品不良反应及其超说明书用药使用分析·················赵熙婷，宋 岐，李春晓，李学林，唐进法（1）：25

321例药源性横纹肌溶解症分析······························································马晓菲，刘星辰（1）：29

某三甲医院2013 - 2017年儿科328例药品不良反应回顾性分析······························································张丽丽，宋洪涛（1）：32

亚胺培南/西司他丁致成人危重症患者中枢神经系统不良反应发生情况及其危险因素分析···············································温爱萍，李丹丹，鲍晓龙（2）：89

25例药物过敏性休克肾上腺素救治再评价·························································褚燕琦，王之舟，刘 琛，陆 璐，曾 艳，沈江华，张青霞，闫素英（2）：93

多粘菌素B导致成人皮肤色素沉着的文献分析······························陈 玥，买淑霞，温欣茹，郭冬杰（3）：161

参麦注射液致过敏性休克文献分析···············张 明，杨 洋，叶伟军，谢法红，辛海莉（3）：165

沙库巴曲缬沙坦致不良反应的文献分析···············徐 虹，梁月琴，夏洪颖，王 丽，李仲昆（4）：227

术中快速静脉滴注万古霉素致严重低血压的文献分析并实例探讨···············沈江华，于雅卉，褚燕琦，胡海量，孔 超（4）：231

399例蛇毒类血凝酶相关药品不良反应报告分析及风险信号挖掘··························································齐 榛，郭代红，姚 翀，杨鸿溢，庞 宁，刘思源，栗啸阳（5）：278

沙库巴曲缬沙坦致不良反应的文献分析······························宋兆芮，王相峰，宋燕青，李艳娇（5）：283

莫西沙星致不良反应134 例文献分析·············································肖丹丹，赵广阔，陈 敏（5）：287

重组人血管内皮抑制素（恩度）联合化疗的不良反应自动监测研究···············王东晓，赖辉莉，郭代红，朱 曼，姚 翀（5）：292

4760例阿司匹林肠溶片不良反应报告分析·············································王 薇，陈兴莉，吴世福（6）：354

磷酸奥司他韦致33例不良反应病例分析·············································刘 洋，夏彬彬，成 华（6）：357

药物利用分析

602例住院患者华法林临床应用分析·············································· 兰艳纤，冯 茜，韦美丹（1）：36

我院糖尿病并发感染患者抗菌药物应用分析····························································· 常 伟，唐扣明（1）：39

2013 - 2017年中国七城市95家医院降胆固醇药物用药分析································方振威，石秀锦，石 佳，林 阳（2）：96

血必净注射液不合理用药情况分析·············································崔海珍，于 倩，王 华（2）：100

我院肝病患者辅助用药药学干预效果评价·············································赵庆国，朱 红，张晓云（2）：104

我院老年糖尿病住院患者降低心血管风险药物使用情况分析······························蔡 俊，韩 丹，聂 力，李 曼（3）：168

108例老年患者抗感染药物用药错误报告分析····························································计紫超，王 昕（3）：172

我院实施干预前后辅助用药重点监控品种使用合理性分析··························································李 冬，胡 辉，刘丽霞，郭 静，李名慧，张 瑞，郭婷婷，伊丽努尔（4）：235

国内神经外科儿童颅内感染现状分析···············陈 玥，李 婷，刘 磊，朱 曼，柴 栋（4）：239

我院肿瘤患者出院带抗肿瘤药物情况及风险分析···············范倩倩，常 青，朱 珠，杨根治，史亦丽（5）：297

我院2018 年度门诊不合理抗菌药物处方的帕累托法分析··························································曹 畅，刘岳金，曾玉兰，钟凯龙，王路敏，曾娜婷，叶岩荣（5）：302

101例替加环素临床应用调查分析······························章 晔，何冰冰，王咪咪，王 敏（5）：305

我院2014 - 2018年肠外肠内营养药品应用分析········································周 鹏，李珂佳，和 洁（6）：361

我院外科预防使用质子泵抑制剂的干预效果分析·············································陈 婧，王 明，尹东锋（6）：365

2014 - 2018年我国七城市DPP-4抑制剂使用现状调查···············周 洋，石秀锦，彭文星，魏娟娟，林 阳（6）：369

药学服务

三种老年人潜在不适当用药评估标准的比较···············································张彩霞，马 卓，崔向丽（1）：43

美法两国对超说明书用药监管对策及其借鉴启示······························································郭俊荣，张 方（1）：46

临床药师干预对呼吸内科药物使用及住院医嘱的效果评价·············································马 静，崔立慧，汤守香（2）：108

药学进展

PD-1/PD-L1抑制剂治疗EGFR突变非小细胞肺癌的研究进展······························智晓玉，王少伟，宋 琪，汪进良（6）：373

案例分析

药物超敏综合征1例并文献回顾································齐 婧，解 方，郝 甜，李承新（1）：50

哌拉西林钠他唑巴坦钠致Stevens-Johnson综合征1例·················任 林，宋惠珠，王祥卫，黄晓娜，蔡小军（1）：54

1例长期应用阿德福韦酯致范可尼综合征的案例分析······························································刘成克，黄翠丽（1）：57

美托洛尔干预Brugada综合征合并高血压1例···············································张哲鹏，单冠男，段利平（1）：60

复方甘草酸苷致低血钾与横纹肌溶解1例并文献分析······························李洪英，李汉高，丁传华，张在丽（2）：112

1例吉西他滨对华法林抗凝作用影响的案例分析····························································朱孔彩，薛文瑞（2）：116

1例帕博利珠单抗致免疫相关性肺炎的病例分析····························································杨彦伟，王伟兰（2）：119

注射用亚胺培南西司他丁钠致顽固性呃逆1例···········································································李 琳（2）：122

紫杉醇联合顺铂化疗致胆汁淤积性药物性肝损伤1例······························邱 刚，苏颖杰，王萌萌，严颐丹（2）：124

乙酰半胱氨酸致咯血1例·············································汤守香，李素娟，马 静（3）：176

氯吡格雷和瑞格列奈相互作用致低血糖1例·············································骆海坤，王丽华，郝利亚（3）：178

伐昔洛韦片致血液透析患者脑病1例·············································王冬雪，徐 锋，侯继秋（3）：181

阿莫西林四联疗法致重症多形红斑药疹1例······························孙文芳，王慧英，张晓兰，刘宪军（3）：183

活力苏口服液致重度肝损伤2例····························································董 清，屠建华（3）：186

甲泼尼龙琥珀酸钠致连续喷射性呕吐1例···············辛秀琴，王冬雪，李 立，侯继秋，张 秀（3）：189

甲泼尼龙联用伏立康唑致类固醇肌病2例··························································徐德铎，卢江燕，潘 珏，胡必杰，吕迁洲，陈万生，陈璋璋（4）：243

伏立康唑致幻觉1例······························雷 露，乔 逸，杨志福，文爱东（4）：246

破伤风人免疫球蛋白致全身皮疹1例并文献分析······························谢法红，李渊源，聂 帅，辛海莉（4）：248

复方甘草酸单铵S致高血压1例··························································王金明，申昌龙，董德强，魏 静，周雪峰，夏修远，曹明雪（4）：251

万古霉素致患儿发热性中性粒细胞减少案例分析···············程刚英，马 钊，姜 茜，周 庆，邓艾平（4）：253

PD-L1抗体Atezolizumab致多脏器免疫相关不良反应1例·············································黄榕彬，徐 萍，刘文辉（4）：256

伏立康唑致视觉障碍1 例·········································································王金明，洪伟勇，申昌龙，董德强，魏 静，曹明雪（5）：309

盐酸胺碘酮注射液致急性过敏2 例·············································李艳娇，王相峰，张文锐（5）：311

利拉鲁肽致心率增快1 例·············································汤智慧，黄克围，裴 育（5）：314

慢性肾脏病患者骨质疏松治疗期间发生高钙血症致急性肾损伤1 例·············································宋 尧，温爱萍，郭 王（5）：317

糖皮质激素冲击致肾功能不全患者抽搐·············································王冬雪，吴淋淋，侯继秋（5）：320

吗啡注射液致短暂性肌无力1 例·············································尹 航，于 倩，邵 丹（5）：322

临床药师参与1例T-DM1致血小板Ⅳ度降低及其治疗的案例分析·············································祁巧玲，俞 平，房文通（6）：377

头孢哌酮钠/舒巴坦钠静脉输注致凝血功能障碍1例··························斯日古楞，郭小彬，乌日汗，杨宏昕（6）：380

哌拉西林钠/舒巴坦钠致继发性血小板增多症伴迟发型皮疹1例·············································于雅卉，沈江华，褚燕琦（6）：383

信 息

《中国药物应用与监测》杂志2019年征订启事 ···········（1）：28

中国研究型医院学会药物评价专业委员会第二届全国临床用药风险监测与防控学术研讨会征文通知················（1）：62

《中国药物应用与监测》稿约 ········································（1）：Ⅰ

《中国药物应用与监测》杂志2019年征订启事 ···········（2）：70

《中国药物应用与监测》开通优秀论文发表绿色通道·························································································（2）：74

案例分析栏目介绍·························································（2）：95

临床评价栏目介绍·······················································（2）：103

临床药师园地栏目介绍···············································（2）：107

《中国药物应用与监测》杂志2019年征订启事 ········（3）：136

临床药师园地栏目介绍···············································（3）：145

临床评价栏目介绍·······················································（3）：149

《中国药物应用与监测》杂志关于投稿的声明 ··········（3）：157

《中国药物应用与监测》开通优秀论文发表绿色通道·······················································································（3）：171

案例分析栏目介绍·······················································（3）：180

临床评价栏目介绍·······················································（4）：207

《中国药物应用与监测》开通优秀论文发表绿色通道·······················································································（4）：211

《中国药物应用与监测》杂志2019年征订启事 ·········（4）：226

临床药师园地栏目介绍···············································（4）：230

案例分析栏目介绍·······················································（4）：242

《中国药物应用与监测》杂志关于投稿的声明 ··········（4）：255

《中国药物应用与监测》杂志关于投稿的声明 ··········（5）：270

《中国药物应用与监测》开通优秀论文发表绿色通道·······················································································（5）：274

《中国药物应用与监测》杂志2020 年征订启事 ·········（5）：319

《中国药物应用与监测》开通优秀论文发表绿色通道·······················································································（6）：334

临床药师园地栏目介绍···············································（6）：353

案例分析栏目介绍·······················································（6）：379

《中国药物应用与监测》杂志2020 年征订启事 ·········（6）：385